Crinetics PharmaceuticalsCRNX

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. R. Scott Struthers, PhD

$3.6B

Market Cap • 14/06/2024

2008

(há 16 anos)
Fundação

2018

(6 years ago)
IPO

NASDAQ

Listagem
Flag of US

San Diego

Sede • California

210

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CRNXSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

1%

1 dia

11/06/2024

1%

1 semana

07/06/2024

-8%

1 mês

14/05/2024

122%

1 ano

14/06/2023

110%

5 anos

14/06/2019

10 anos

Histórico